Established in 2020, Bio-Next Pharmaceuticals is a wholly owned subsidiary of Bio-Labs (Pvt) Ltd. which is a state-of-the-art manufacturing facility in Islamabad for manufacturing of Carbapenems injectables to cater to the need of prevailing MDR cases. Initially we have received registrations of Imipenem/Cilastatin & Meropenem Injections. Ertapenem and Doripenem are in the development phase and will get registrations soon.

At Bio-Next we have always believed in continuous R&D towards the development of new pharmaceutical formulations. Our new product development program generally includes pre-formulation studies, excipient studies, analytical methods development, validation, formulation development and optimization, formal stability studies and manufacturing process development.

For further details please visit our website https://bionext-pharma.com/